Calamos Wealth Management LLC Sells 7,442 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Calamos Wealth Management LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 18.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 32,729 shares of the healthcare conglomerate's stock after selling 7,442 shares during the period. UnitedHealth Group makes up approximately 0.9% of Calamos Wealth Management LLC's investment portfolio, making the stock its 23rd largest holding. Calamos Wealth Management LLC's holdings in UnitedHealth Group were worth $17,142,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Financial Management Professionals Inc. lifted its holdings in UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after acquiring an additional 17 shares in the last quarter. Richwood Investment Advisors LLC lifted its holdings in shares of UnitedHealth Group by 0.4% in the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after purchasing an additional 20 shares in the last quarter. Global Wealth Strategies & Associates lifted its holdings in shares of UnitedHealth Group by 28.6% in the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after purchasing an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 1.0% in the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after purchasing an additional 21 shares in the last quarter. Finally, Retirement Planning Group LLC lifted its holdings in shares of UnitedHealth Group by 5.1% in the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock valued at $225,000 after purchasing an additional 21 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded up $1.13 during trading on Friday, reaching $308.69. 6,161,145 shares of the stock were exchanged, compared to its average volume of 7,543,771. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a market cap of $280.03 billion, a PE ratio of 12.93, a PEG ratio of 1.48 and a beta of 0.45. The stock has a 50-day moving average price of $327.18 and a 200-day moving average price of $448.90. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the prior year, the firm earned $6.91 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a $2.21 dividend. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 2.86%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's payout ratio is 37.02%.

Insiders Place Their Bets

In related news, Director Kristen Gil purchased 3,700 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director owned 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the business's stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer owned 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock valued at $31,607,768 in the last quarter. Company insiders own 0.28% of the company's stock.

Analysts Set New Price Targets

UNH has been the topic of a number of research reports. Wolfe Research cut their price target on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a report on Tuesday, May 20th. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Piper Sandler lowered their target price on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a research report on Tuesday, June 3rd. Wells Fargo & Company reaffirmed an "overweight" rating on shares of UnitedHealth Group in a research report on Friday, June 6th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and an average price target of $415.57.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.